Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.
about
Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?The roles of mesenchymal stem cells in tumor inflammatory microenvironmentThe Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationCarcinoma-associated fibroblasts: orchestrating the composition of malignancyFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assayBone marrow-derived mesenchymal stem cells drive lymphangiogenesis.Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblastsMesenchymal Stem Cells Shed Amphiregulin at the Surface of Lung Carcinoma Cells in a Juxtacrine Manner.Bone metastasis and the metastatic niche.Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis.Cancer subclonal genetic architecture as a key to personalized medicine.A novel role of MMP-13 for murine DC function: its inhibition dampens T-cell activation.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationTissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.The hypoxic tumour microenvironment.New Insights into the Tumor Microenvironment Utilizing Protein Array Technology.The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1.
P2860
Q26798274-0822FB57-5D2C-4205-A0CE-027380CC9133Q26823759-E262BAA5-A9DC-41B8-8994-CF76348D0752Q28073691-6D3428A4-AA75-4ADD-B7A2-CC5EAA9CBF62Q28078667-0613E8BE-EFB8-4AB0-9B43-007BB4E05710Q28082504-FC4F123E-F071-4AE7-98AE-4106EAA1DA40Q28385088-B0A86A4A-7D70-4A5D-9056-916731B49E32Q34183523-24796FDF-B135-44D6-A768-322D26B229A8Q35176121-1CA3C394-6D24-48E7-A166-E23C70B04735Q35990316-A64E1B88-8FDD-4C03-8DC1-9D4A54D11D59Q36259458-2BB5D14C-2888-4E64-91ED-3BA2D08E5F9AQ37338336-FF0A99C0-00CA-4D86-95D0-BBBA6D0D609CQ37448116-20A88968-5FF0-48CF-B921-4B447BB2D210Q39964360-DD5A209A-FBFA-4067-9CF2-5843D2120204Q41879186-8FC8D8BA-0DB7-4F82-8E11-45FA35F3F734Q42127261-883BD225-F844-4CEC-93BE-26FA3B09224CQ48181172-EFB1C4B4-4D63-411C-B187-EC9949072B52Q50042197-3AA589A2-EA97-4B55-900F-2F246008935AQ55176664-EF62C8FB-C307-479D-B560-580FCE5B7C07
P2860
Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@ast
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@en
type
label
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@ast
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@en
prefLabel
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@ast
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@en
P2093
P2860
P356
P1433
P1476
Bone marrow-derived myofibrobl ...... roteinase 13 in primary tumor.
@en
P2093
Agnes Noel
André Gothot
Anne Masset
Françoise Bruyère
Gunilla Høyer-Hansen
Ida K Lund
Jenny Paupert
Julie Lecomte
Ludovic Maertens
Marie Delgaudine
P2860
P304
P356
10.1593/NEO.121092
P577
2012-10-01T00:00:00Z